Provided by Tiger Trade Technology Pte. Ltd.

ANI Pharmaceuticals

75.35
-1.9700-2.55%
Post-market: 75.350.00000.00%19:39 EDT
Volume:379.16K
Turnover:28.69M
Market Cap:1.73B
PE:16.60
High:77.81
Open:77.33
Low:74.81
Close:77.32
52wk High:99.50
52wk Low:70.15
Shares:22.97M
Float Shares:20.28M
Volume Ratio:1.41
T/O Rate:1.87%
Dividend:- -
Dividend Rate:- -
EPS(TTM):4.54
EPS(LYR):3.32
ROE:20.46%
ROA:5.45%
PB:2.90
PE(LYR):22.70

Loading ...

ANI Pharmaceuticals Q2 Adjusted EPS USD 2.21 Vs. IBES Estimate USD 2.05

Reuters
·
Aug 07

ANI Pharmaceuticals Q2 Adjusted Ebitda USD 71.6 Million

THOMSON REUTERS
·
Aug 07

ANI Pharmaceuticals Q2 Net Income USD 24.7 Million

THOMSON REUTERS
·
Aug 07

ANI Pharmaceuticals Reports Record Second Quarter 2026 Financial Results

THOMSON REUTERS
·
Aug 07

Calendar of U.S. Earnings Expected in the Week Ahead

Dow Jones
·
Aug 07

Barclays Sticks to Their Buy Rating for ANI Pharmaceuticals (ANIP)

TIPRANKS
·
Aug 05

Earning Preview: ANI Pharmaceuticals this quarter’s revenue is expected to increase by 36.70%, and institutional views are bullish

Earnings Agent
·
Jul 31

ANI Pharmaceuticals to Discuss Second Quarter 2026 Financial Results on August 7, 2026 at 8:00 a.m. ET

GlobeNewswire
·
Jul 24

ANI Pharmaceuticals (ANIP) Stock Looks Fairly Valued With Strong Returns But Mixed Earnings

Simply Wall St.
·
Jul 18

ANI Pharmaceuticals Initiated at Hold by Canaccord Genuity

Dow Jones
·
Jul 17

U.S. Research Roundup-ibm, MSCI, US Bancorp

Reuters
·
Jul 17

Ani Pharmaceuticals Announces Intent to Appeal Rulings in CG Oncology Matter

Reuters
·
Jul 17

ANI Pharmaceuticals intends to appeal rulings in CG Oncology matter

TIPRANKS
·
Jul 17

ANI Pharma Plans Delaware Supreme Court Appeal in CG Oncology Dispute

Reuters
·
Jul 17

ANI Pharmaceuticals - Trial Court Denies ANI Pharmaceuticals' Motion for New Trial and Judgment

THOMSON REUTERS
·
Jul 17

ANI Pharmaceuticals Announces Intent to Appeal Rulings in CG Oncology Matter

THOMSON REUTERS
·
Jul 17

ANI Pharmaceuticals Inc: Continue to Seek to Recover Value of Assets it Sold to CG Oncology in 2010

THOMSON REUTERS
·
Jul 17

ANI Pharmaceuticals initiated with a Hold at Canaccord

TIPRANKS
·
Jul 17

ANI Pharmaceuticals SVP, General Counsel Meredith Cook Disposes of 500 Common Shares for $40,920

Reuters
·
Jul 15

Wall Street Analysts Are Bullish on Top Healthcare Picks

TIPRANKS
·
Jul 14